𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dietary treatment eliminates succinylacetone from the urine of a patient with tyrosinaemia type 1

✍ Scribed by M. D. Bain; P. Purkiss; M. Jones; P. Bingham; T. E. Stacey; R. A. Chalmers

Publisher
Springer
Year
1990
Tongue
English
Weight
305 KB
Volume
149
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The identification of five novel mutatio
The identification of five novel mutations in the lysosomal acid a-(1,4) glucosidase gene from patients with glycogen storage disease type II
✍ Clare E. Beesley; Anne H. Child; Magdi H. Yacoub πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 165 KB πŸ‘ 2 views

The autosomal recessive disorder Glycogen Storage Disease Type II (GSDII) is caused by a deficiency in the lysosomal enzyme acid -glucosidase. We have optimised a procedure to use fluorescent DNA sequencing technology to screen for mutations within the -glucosidase gene from UK patients with GSDII.

An Ξ±1 II Gly913 to Cys substitution prev
An Ξ±1 II Gly913 to Cys substitution prevents the matrix incorporation of type II collagen which is replaced with type I and III collagens in cartilage from a patient with hypochondrogenesis
✍ Mundlos, Stefan; Chan, Danny; McGill, Jim; Bateman, John F. πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 37 KB πŸ‘ 1 views

A heterozygous mutation in the COL2A1 gene was identified in a patient with hypochondrogenesis. The mutation was a single nucleotide transition of G3285T that resulted in an amino acid substitution of Cys for Gly9I3 in the al(I1) chain of type I1 collagen. This amino acid change disrupted the obliga